Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-139,907 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
N/A
-1,726,166 Reduced 92.5%
139,907 $2.46 Million
Q2 2021

Aug 16, 2021

BUY
N/A
831,082 Added 80.3%
1,866,073 $18.1 Million
Q1 2021

May 17, 2021

BUY
N/A
273,526 Added 35.92%
1,034,991 $11.1 Million
Q4 2020

Feb 16, 2021

SELL
N/A
-69,032 Reduced 8.31%
761,465 $11.2 Million
Q3 2020

Nov 16, 2020

BUY
N/A
203,687 Added 32.5%
830,497 $11.8 Million
Q2 2020

Aug 14, 2020

SELL
N/A
-27,971 Reduced 4.27%
626,810 $5.07 Million
Q1 2020

May 15, 2020

BUY
N/A
654,781 New
654,781 $2.65 Million

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.